| abstract |
The present disclosure is acceptable salts of amine-indole 2,3-dioxygenase claim 1 (IDO1) inhibitor or a pharmaceutically of formula I (wherein X, L, n, m, R 1, R 2a, R 2b, R n, R m and R t are as defined herein, as well as pharmaceutical compositions comprising a compound of formula I or a pharmaceutically acceptable salt thereof, and methods of using the same to treat conditions mediated by IDO1 do. |